首页 | 本学科首页   官方微博 | 高级检索  
检索        

多学科综合治疗模式在肾癌伴静脉癌栓患者临床诊治中的作用
引用本文:刘茁,唐世英,范雯怡,张洪宪,田晓军,王国良,张树栋,黄毅,王俊杰,王皓,彭冉,刘剑羽,何为,葛辉玉,王淑敏,李丽伟,陆敏,郑清,蒋斌,赵鸿,马力文,马潞林.多学科综合治疗模式在肾癌伴静脉癌栓患者临床诊治中的作用[J].现代泌尿外科杂志,2019(8):634-638,644.
作者姓名:刘茁  唐世英  范雯怡  张洪宪  田晓军  王国良  张树栋  黄毅  王俊杰  王皓  彭冉  刘剑羽  何为  葛辉玉  王淑敏  李丽伟  陆敏  郑清  蒋斌  赵鸿  马力文  马潞林
作者单位:北京大学第三医院泌尿外科;北京大学第三医院医务处;北京大学第三医院肿瘤放疗科;北京大学第三医院放射科;北京大学第三医院超声科;北京大学第三医院病理科;北京大学第三医院麻醉科;北京大学第三医院普通外科;北京大学第三医院心脏外科;北京大学第三医院肿瘤化疗科
摘    要:目的通过分析北京大学第三医院肾癌伴静脉癌栓肿瘤多学科综合治疗(MDT)模式的开展情况,总结泌尿系肿瘤MDT模式在肾癌伴下腔静脉癌栓患者临床诊治中的作用。方法回顾性分析2015年2月至2018年7月我院收治的149例肾癌合并下腔静脉癌栓患者的临床资料,所有患者均行MDT模式学术讨论。MDT模式由泌尿外科、肿瘤放疗科、放射科、超声诊断科、病理科、麻醉科、普通外科、心脏外科、肿瘤化疗科等多学科专家围绕一个肾癌伴下腔静脉癌栓患者进行讨论,在综合各学科意见的基础上为患者提供诊疗方案。149例患者中,男性109例,女性40例。年龄2.5~83岁,平均(57.2±13.8)岁。肿瘤侧别左侧53例,右侧95例,双侧1例。合并Mayo:0级者32例、Ⅰ级者37例、Ⅱ级者46例、Ⅲ级者20例、Ⅳ级者13例,其中1例双侧肾癌伴静脉癌栓患者,左侧Mayo 0级,右侧MayoⅠ级。结果 149例患者在MDT的协作下进行临床诊治,包括诊断、治疗计划和随后的手术。根据放射科、超声诊断科、麻醉科、普通外科、心脏外科及泌尿外科多学科讨论分析,获得精确术前评估,从而使得更多的患者获得手术机会,同时降低术后并发症的发生风险。根据病理科的患者术后病理回报情况以及肿瘤化疗科、肿瘤放疗科的联合讨论,决定下一步随访策略及术后辅助治疗。所有患者均根据MDT团队的讨论结果进行临床治疗决策,手术均顺利完成,未出现术中死亡病例。行腹腔镜手术66例,开放手术70例,腹腔镜联合开放途径13例。平均手术时间(332.8±121.3)(136~561)min,平均术中出血(1 367.6±1 610.4)(20~10 000)mL,平均输注悬浮红细胞(1 586.1±1 377.7)(0~10 400)mL。术后平均住院时间(10.6±5.4)(4~39)d。36例(24.2%)患者出现术后并发症,其中严重并发症(改良Clavien分级≥3级)9例。术后随访方面,共139例(93.3%)患者获得随访,10例患者失访。平均随访时间(11.3±8.6)(1~37)个月。术后行靶向治疗患者50例。随访期内,患者因肿瘤死亡12例,肿瘤复发5例,肿瘤转移28例。结论对肾癌伴下腔静脉癌栓患者应用MDT模式能有效发挥各个学科的优势,提高诊治效率,使患者得到优化的多学科治疗方案。

关 键 词:多学科综合治疗模式  肾癌  癌栓  下腔静脉

The roles of multi-disciplinary treatment(MDT) in the management of renal cell carcinoma with tumor thrombus
LIU Zhuo,TANG Shi-ying,FAN Wen-yi,ZHANG Hong-xian,TIAN Xiao-jun,WANG Guo-liang,ZHANG Shu-dong,HUANG Yi,WANG Jun-jie,WANG Hao,PENG Ran,LIU Jian-yu,HE Wei,GE Hui-yu,WANG Shu-min,LI Li-wei,LU Min,ZHENG Qing,JIANG Bin,ZHAO Hong,MA Li-wen,MA Lu-lin.The roles of multi-disciplinary treatment(MDT) in the management of renal cell carcinoma with tumor thrombus[J].Journal of MOdern Urology,2019(8):634-638,644.
Authors:LIU Zhuo  TANG Shi-ying  FAN Wen-yi  ZHANG Hong-xian  TIAN Xiao-jun  WANG Guo-liang  ZHANG Shu-dong  HUANG Yi  WANG Jun-jie  WANG Hao  PENG Ran  LIU Jian-yu  HE Wei  GE Hui-yu  WANG Shu-min  LI Li-wei  LU Min  ZHENG Qing  JIANG Bin  ZHAO Hong  MA Li-wen  MA Lu-lin
Institution:(Department of Urology,Third Hospital of Peking University,100083 Beijing,China;Department of Tumor Chemotherapy,Third Hospital of Peking University,100083 Beijing,China;Medical Department,Third Hospital of Peking University,100083 Beijing,China;Department of Tumor Radiotherapy,Third Hospital of Peking University,100083 Beijing,China;Department of Radiology,Third Hospital of Peking University,100083 Beijing,China;Department of Ultrasound,Third Hospital of Peking University,100083 Beijing,China;Department of Pathology,Third Hospital of Peking University,100083 Beijing,China;Department of Anesthesiology,Third Hospital of Peking University,100083 Beijing,China;Department of General Surgery,Third Hospital of Peking University,100083 Beijing,China;Department of Cardiac Surgery,Third Hospital of Peking University,100083 Beijing,China)
Abstract:LIU Zhuo;TANG Shi-ying;FAN Wen-yi;ZHANG Hong-xian;TIAN Xiao-jun;WANG Guo-liang;ZHANG Shu-dong;HUANG Yi;WANG Jun-jie;WANG Hao;PENG Ran;LIU Jian-yu;HE Wei;GE Hui-yu;WANG Shu-min;LI Li-wei;LU Min;ZHENG Qing;JIANG Bin;ZHAO Hong;MA Li-wen;MA Lu-lin(Department of Urology,Third Hospital of Peking University,100083 Beijing,China;Department of Tumor Chemotherapy,Third Hospital of Peking University,100083 Beijing,China;Medical Department,Third Hospital of Peking University,100083 Beijing,China;Department of Tumor Radiotherapy,Third Hospital of Peking University,100083 Beijing,China;Department of Radiology,Third Hospital of Peking University,100083 Beijing,China;Department of Ultrasound,Third Hospital of Peking University,100083 Beijing,China;Department of Pathology,Third Hospital of Peking University,100083 Beijing,China;Department of Anesthesiology,Third Hospital of Peking University,100083 Beijing,China;Department of General Surgery,Third Hospital of Peking University,100083 Beijing,China;Department of Cardiac Surgery,Third Hospital of Peking University,100083 Beijing,China)
Keywords:multi-disciplinary treatment  renal carcinoma  tumor thrombus  inferior vena cava
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号